Literature DB >> 2446560

Humoral pathogenesis of myasthenia gravis.

D B Drachman1, S de Silva, D Ramsay, A Pestronk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2446560     DOI： 10.1111/j.1749-6632.1987.tb51285.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  21 in total

1.  Autonomic "myasthenia": the case for an autoimmune pathogenesis.

Authors:  Daniel B Drachman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

3.  Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Authors:  Alexandra Pevzner; Benedikt Schoser; Katja Peters; Nicoleta-Carmen Cosma; Andromachi Karakatsani; Berthold Schalke; Arthur Melms; Stephan Kröger
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

4.  Phenotypic and functional characterization of T cells from patients with myasthenia gravis.

Authors:  F Mokhtarian; M Pino; W Ofosu-Appiah; D Grob
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 5.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

6.  Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.

Authors:  S J Tzartos; E Morel; A Efthimiadis; A F Bustarret; J D'Anglejan; A A Drosos; H A Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

7.  Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms?

Authors:  E Morel; B Vernet-der Garabedian; B Eymard; F Raimond; F A Bustarret; J F Bach
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 8.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

9.  Development of an assay for modulating anti-acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line.

Authors:  B W Lyons; L L Wu; M E Astill; J T Wu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 10.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.